EuroIntervention PCRonline - Connecting with the community

Richard Rapoza

23 articles

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

EuroIntervention 2016;12:1090-1101 published online ahead of print September 2016

Published in Volume 12 Number 9, October 2016

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data

EuroIntervention 2015;11:746-756 published online ahead of print October 2014

Published in Volume 11 Number 7, November 2015

Technology limitations of BRS in bifurcations

EuroIntervention 2015;11:V155-V158

Published in Volume 11 Supplement V, May 2015

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial

EuroIntervention 2015;10:1299-1306 published online ahead of print April 2014

Published in Volume 10 Number 11, March 2015

Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model

EuroIntervention 2014;10:833-841

Published in Volume 10 Number 7, November 2014

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

EuroIntervention 2014;9:1271-1284 published online ahead of print December 2013

Published in Volume 9 Number 11, March 2014

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

EuroIntervention 2013;9:709-720 published online ahead of print April 2013

Published in Volume 9 Number 6, October 2013

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial

EuroIntervention 2012;8:352-358 published online ahead of print November 2011

Published in Volume 8 Number 3, July 2012

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study

EuroIntervention 2012;8:214-224

Published in Volume 8 Number 2, June 2012

In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis

EuroIntervention 2012;7:1461-1463 publish online ahead of print September 2011

Published in Volume 7 Number 12, April 2012

In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis

EuroIntervention 2012;7:1227-1235 publish online ahead of print December 2011

Published in Volume 7 Number 10, February 2012

Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application

EuroIntervention 2011;7:386-399 published online ahead of print January 2011

Published in Volume 7 Number 3, July 2011

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

Published in Volume 7 Supplement M, May 2011

Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold

Published in Volume 7 Supplement M, May 2011

Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up

Published in Volume 7 Supplement M, May 2011

Evaluation of preclinical safety of Absorb cohort b bioresorbable vascular scaffold by employing multiple modalities

Published in Volume 7 Supplement M, May 2011

Preclinical insights into clinical safety and delivery of vascular restoration therapy by a bioresorbable vascular scaffold

Published in Volume 7 Supplement M, May 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2010;6:447-453 published online ahead of print June 2010

Published in Volume 6 Number 4, September 2010

Safety of overlapping the bioresorbable vascular scaffold in a porcine coronary artery model

Published in Volume 6 Supplement H, May 2010

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

EuroIntervention 2010;5:932-938 - DOI10.4244/EIJV5I8A157

Published in Volume 5 Number 8, April 2010

Design principles and performance of bioresorbable polymeric vascular scaffolds

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F15-F22

Published in Volume 5 Supplement F, December 2009

Long term safety and bio-absorption of a fully bio-absorbable everolimuseluting vascular implant in porcine and rabbit arterial models

Published in Volume 5 Supplement E, May 2009